Logix Smart COVID-19 Test
SARS-CoV-2 Infection
Key Facts
About Co-Diagnostics
Co-Diagnostics is a molecular diagnostics company focused on developing, manufacturing, and marketing tests based on its patented CoPrimer™ technology platform, which aims to improve PCR specificity and sensitivity. The company has commercialized tests for diseases including tuberculosis, hepatitis, HPV, malaria, and SARS-CoV-2, and operates a dual revenue model through direct product sales and IP licensing via its joint venture in India. Its strategy centers on expanding its infectious disease portfolio, growing its global distribution network, and leveraging its platform's flexibility for partnerships and new assay development.
View full company profileTherapeutic Areas
Other SARS-CoV-2 Infection Drugs
| Drug | Company | Phase |
|---|---|---|
| Talis One COVID-19 Test | Talis Biomedical | Commercial (EUA) |
| COV19 qcLAMP Kit | BIOPIX-T | Approved |
| GenBody COVID-19 Ag Test | GenBody | Approved |
| CovidDetect | Prime Discoveries | Commercial |
| FabenCOV® (e-FabRIC) | Fabentech | Phase 2 |
| Favipiravir | Viriom | Bioequivalence |
| EDP-323 | Enanta Pharmaceuticals | Phase 1 |
| InteliSwab® COVID-19 Rapid Antigen Test | OraSure Technologies | Approved |